Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3199-3205

  Ki, M ^a   Srinivasan, U ^b   Oh, K Y ^c   Kim, M Y ^d   Shin, J H ^e   Hong, H L ^f   Dang, T ^b   Britt, Z ^b   Foxman, B ^b  

^a Eulji University School of Medicine   (South Korea)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Eulji University   (South Korea)

^d Catholic Kwandong University   (South Korea)

^e Eulji General Hospital   (South Korea)

^f Seoul Medical Science Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; SOUTH KOREA; STREPTOCOCCUS AGALACTIAE;

ANTI-BACTERIAL AGENTS; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPUBLIC OF KOREA; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84867996769     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1685-8     Document Type: Article

References (36)

1. Gibbs RS, Schrag S, Schuchat A (2004) Perinatal infections due to group B streptococci. Obstet Gynecol 104(5 Pt 1):1062-1076. doi: 10.1097/01.AOG. 0000144128.03913.c2
2. Lee BK, Song YR, Kim MY, Yang JH, Shin JH, Seo YS, Oh KY, Yoon HR, Pai SY, Foxman B, Ki M (2010) Epidemiology of group B streptococcus in Korean pregnant women. Epidemiol Infect 138(2):292-298. doi: 10.1017/S0950268809990859
3. Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC (1997) Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis 16(10):753-756
4. Kim M, Jang H, Chang D, Cho J, Kim Y, Choi H, Kim S, Lee J, Hwang K, Kang B (2006) Group B streptococcal colonization rate in Korean pregnant women. Korean J Obstet Gynecol 49(2):337-344
5. Choi K, Koh S, Lee J, Park J, Hwang S, Lee B, Lee W (2002) Clinical significance of group B streptococcal infection in pregnant women. Korean J Obstet Gynecol 45(5):811-815
6. Lee J, Kim S, Lee H, Kim S, Choi S, Sung I, Kang J, Chun C (2003) A clinical study of group B streptococcal infection: five years experience. J Korean Soc Neonatol 10(2):226-234
7. Scheld WM (2003) Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 9(1):1-9
8. Hooper DC (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2(9):530-538
9. Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, Itoh Y, Ezaki T (2003) First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob Agents Chemother 47(11):3605-3609
10. Biedenbach DJ, Toleman MA, Walsh TR, Jones RN (2006) Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 55(2):119-127
11. Wu HM, Janapatla RP, Ho YR, Hung KH, Wu CW, Yan JJ, Wu JJ (2008) Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 52(5):1888-1890
12. von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R (2003) A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J Clin Microbiol 41(5):2166-2169
13. Ulett KB, Benjamin WH Jr, Zhuo F, Xiao M, Kong F, Gilbert GL, Schembri MA, Ulett GC (2009) Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J Clin Microbiol 47(7):2055-2060. doi: 10.1128/JCM.00154-09
14. Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN, Doern GV (2000) Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 183(4):859-862. doi: 10.1067/mob.2000.108839
15. Brueggemann AB, Coffman SL, Rhomberg P, Huynh H, Almer L, Nilius A, Flamm R, Doern GV (2002) Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob Agents Chemother 46(3):680-688
16. Seo YS, Srinivasan U, Oh KY, Shin JH, Chae JD, Kim MY, Yang JH, Yoon HR, Miller B, DeBusscher J, Foxman B, Ki M (2010) Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci 25(6):817-823. doi: 10.3346/jkms.2010.25.6.817
17. National Committee for Clinical Laboratory Standards (NCCLS) (2002) Performance Standards for Antimicrobial Susceptibility Testing, vol M100-S12. Table 2 H. Wayne, PA, USA
18. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF (2004) Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 42(1):146-150
19. Zhang L, Reddi U, Srinivasan U, Li S, Borchardt SM, Pillai P, Mehta P, Styka AN, Debusscher J, Marrs CF, Foxman B (2008) Combining microarray technology and molecular epidemiology to identify genes associated with invasive group B streptococcus. Interdiscip Perspect Infect Dis 2008(314762):1-10. doi: 10.1155/2008/314762
20. Zhang L, Srinivasan U, Marrs CF, Ghosh D, Gilsdorf JR, Foxman B (2004) Library on a slide for bacterial comparative genomics. BMC Microbiol 4:12. doi: 10.1186/1471-2180-4-12
21. Marrs CF, Zhang L, Tallman P, Manning SD, Somsel P, Raz P, Colodner R, Jantunen ME, Siitonen A, Saxen H, Foxman B (2002) Variations in 10 putative uropathogen virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol 51(2):138-142
22. Harris TO, Shelver DW, Bohnsack JF, Rubens CE (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111(1):61-70. doi: 10.1172/JCI16270
23. Bhavnani SM, Hammel JP, Jones RN, Ambrose PG (2005) Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis 51(1):31-37
24. Tazi A, Gueudet T, Varon E, Gilly L, Trieu-Cuot P, Poyart C (2008) Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerg Infect Dis 14(2):349-350
25. Wehbeh W, Rojas-Diaz R, Li X, Mariano N, Grenner L, Segal-Maurer S, Tommasulo B, Drlica K, Urban C, Rahal JJ (2005) Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob Agents Chemother 49(6):2495-2497
26. Fuller JD, Low DE (2005) A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 41(1):118-121. doi: 10.1086/430829
27. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, Klugman KP (2004) Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 48(9):3491-3497. doi: 10.1128/AAC.48.9. 3491-3497.2004
28. Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev: MMBR 61(3):377-392
29. Pestova E, Millichap JJ, Noskin GA, Peterson LR (2000) Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother 45(5):583-590
30. Takei M, Fukuda H, Kishii R, Hosaka M (2001) Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob Agents Chemother 45(12):3544-3547. doi: 10.1128/AAC.45.12.3544-3547.2001
31. Baranova NN, Neyfakh AA (1997) Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae. Antimicrob Agents Chemother 41(6):1396-1398
32. Jumbe NL, Louie A, Miller MH, Liu W, Deziel MR, Tam VH, Bachhawat R, Drusano GL (2006) Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 50(1):310-317. doi: 10.1128/AAC.50.1.310-317.2006
33. Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19(2):382-402. doi: 10.1128/CMR.19.2.382-402.2006
34. Tran JH, Jacoby GA, Hooper DC (2005) Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49(1):118-125
35. Rodriguez-Martinez JM, Velasco C, Briales A, Garcia I, Conejo MC, Pascual A (2008) Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother 61(6):1240-1243. doi: 10.1093/jac/dkn115
36. Ince D, Hooper DC (2003) Quinolone resistance due to reduced target enzyme expression. J Bacteriol 185(23):6883-6892